Low vaspin levels linked to increased coronary artery disease

Written By :  Hina Zahid
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-03-23 11:30 GMT   |   Update On 2020-03-23 11:30 GMT

Researchers have found that low serum vaspin levels are associated with coronary artery stenosis. Plasma vaspin concentration reflects possible endothelial dysfunction in CAD patients and correlates with CAD severity. Plasma vaspin concentration is associated with metabolic syndrome and obesity parameters.

The relationship between serum vaspin levels and metabolic or coronary artery disease is currently of interest for researchers. Although adipokine concentrations have been shown to be increased significantly in atherosclerotic lesions, the role of adipokines in the atherosclerotic process remains to be elucidated. 

Researchers at the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey  have conducted a study to find out associations between Vaspin Levels and Coronary Artery Disease.

Vaspin is a new biological marker of CAD. Low serum vaspin levels are associated with coronary artery stenosis. Plasma vaspin concentration reflects possible endothelial dysfunction in CAD patients and correlates with CAD severity. Plasma vaspin concentration is associated with metabolic syndrome and obesity parameters. The ultimate goal regarding vaspin is to detect and prevent diseases caused by atherosclerosis, as well as to preserve vascular health and contribute to public health.

Advertisement

Vascular inflammation triggered by vaspin inhibits atherogenesis by suppressing macrophage foam cell formation and vascular smooth muscle cell migration and proliferation. Vaspin also contributes to plaque stabilization by increasing collagen content and reducing the intraplaque macrophage to vascular smooth muscle cell ratio. The therapeutic goal concerning vaspin is to fight atherosclerosis and related diseases, as well as to maintain vascular health.

CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the EMBASE, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

For more details click the link: http://dx.doi.org/10.15212/CVIA.2019.0565 

Tags:    
Article Source : Cardiovascular Innovations and Applications

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News